Patient sex does not affect endoscopic outcomes of biologicals in inflammatory bowel disease but is associated with adverse events

por Lie, Mitchell R. K. L., Paulides, Emma, van der Woude, C. Janneke
Publicado 2020

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre L...

por Paulides, Emma, Lie, Mitchell R K L, van der Woude, Christien Janneke
Publicado 2022

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

por Lie, Mitchell R. K. L., van der Giessen, Janine, Fuhler, Gwenny M., de Lima, Alison, Peppelenbosch, Maikel P., van der Ent, Cokkie, van der Woude, C. Janneke
Publicado 2018